Mycoses

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2015-08-25
Clinical Trial Update: Evaluation of Treatment and Prophylaxis of Invasive Fungal Infections in Immuncompromised Patients in Austria (Study P05532)(WITHDRAWN)
A Merck-sponsored clinical trial evaluating treatment and prophylaxis of invasive fungal infections in immunocompromised patients in Austria…
EMA withdrawal · 2009-08-04
EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe
EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.